oncology
MSD’s Keytruda combo therapy significantly improves survival in advanced renal cell carcinoma
February 18, 2019Sales and Marketing Cancer, MSD, Merck Sutent, Pfizer, inlyta, keytruda, oncology, rcc, renal cell carcinoma
Merck & Co’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib) significantly extended the lives of those with advanced renal …
Researchers find new type of cell membrane which causes cancer cells to explode
February 13, 2019Research and Development Cancer, FTY720, cell membranes, molecules, oncology
Researchers at the Medical University of South Carolina (MUSC) have discovered a new type of cell membrane complex which causes …
Clinigen shares soar after $210m Novartis cancer drug deal
February 13, 2019Research and Development Cancer, Clinigen, Novartis, Proleukin, UK, US, oncology
British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …
Genentech to develop ‘highly active cytokine’ with Xancor in deal worth $300m
February 6, 2019Research and Development Cancer, Genetech, IL-15 cytokine, Roche, Xancor, oncology
Roche’s Genentech unit has agreed to pay $120 million upfront as part of a research and licensing deal with California-based …
Obesity-related cancers on the rise amongst millennials
February 4, 2019Sales and Marketing Cancer, obesity, oncology, young people
Cancers related to obesity are on the rise in young adults, according to findings from the American Cancer Society, published …
Top Ten most popular articles on Pharmafile.com this week!
February 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10
Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …
Israeli biotech claims it has developed cure for cancer
January 30, 2019Research and Development Cancer, MuTaTo, biotech, israel, lung cancer, oncology
An Israeli biotech has claimed that it has developed a complete cure for cancer. Speaking to the Jerusalem Post, Dan …
Diagnosis at stages 1-3 increases cancer survival rate significantly
January 25, 2019Medical Communications Cancer, England, NHS, health, oncology
Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following …
GSK acquires oncology firm Tesaro for $5.1 billion
January 23, 2019Research and Development Cancer, GSK, Tesaro, oncology, ovarian cancer
British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion). Tesaro, a Massachusetts-based clinical stage …
Canada Health approves Novartis’ CAR-T therapy Kymriah
January 18, 2019Medical Communications CAR T, CAR-T, Canada, Cancer, Kymriah, Novartis, oncology
Health Canada has approved Novartis’ CAR-T therapy Kymriah for use in paediatric and young adult patients aged between three and …
More young people surviving cancer in England, despite significant economic divide
January 17, 2019Medical Communications, Research and Development Cancer, England, UK, health public health, oncology, young people
Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …
Breast cancer cells can be transformed into fat cells using combination therapy, study shows
January 16, 2019Research and Development Cancer, EMT, breast cancer, cells, oncology, tumours
An innovative cancer treatment can turn malignant breast cancer cells into fat cells, thus preventing the formation of metastases (the …
Tumours with large number of mutations respond better to immunotherapies, study shows
January 15, 2019Manufacturing and Production, Research and Development Cancer, immunotherapy, nature, oncology, research, tumour
Tumours with a large number of DNA mutations are more likely to respond to immunotherapies than cancers with fewer mutations, …
Dutch health minister attacks Novartis over orphan drug price hike
January 15, 2019Manufacturing and Production Cancer, Lutathera, NL, Netherlands, Novartis, oncology
Dutch health minister Bruno Bairns has called for a meeting with Swiss multinational Novartis after the multibillion-dollar firm introduced a …
AstraZeneca hire controversial cancer doc to head new Oncology R&D unit
January 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology
The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …
Latest content
FibroFind appoints Lee Borthwick as CEO
